Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henrik S Rasmussen

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
The New England Journal of Medicine|April 18, 2015
New agents for hyperkalemiaDavid K Packham, Henrik S Rasmussen, Bhupinder Singh
Plos One|December 23, 2014
Characterization of structure and function of ZS-9, a K+ selective ion trapFiona Stavros, Alex Yang, Alejandro Leon, et al.
Kidney International|February 5, 2015
A phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, ZS-9, is safe and efficientStephen R Ash, Bhupinder Singh, Philip T Lavin, et al.
Drug Discovery Today|November 9, 2001
Looking into anti-angiogenic gene therapies for disorders of the eyeHenrik S. Rasmussen, Camilla S. Rasmussen, Rebecca G. Durham, et al.
The Lancet. Oncology|November 9, 2002
Radiation-induced tumour necrosis factor-alpha expression: clinical application of transcriptional and physical targeting of gene therapyRalph R Weichselbaum, Donald W Kufe, Samuel Hellman, et al.
The Journal of Allergy and Clinical Immunology|December 26, 2021
An open-label, proof-of-concept study of lirentelimab for antihistamine-resistant chronic spontaneous and inducible urticariaSabine Altrichter, Petra Staubach, Malika Pasha, et al.
JCI Insight|August 30, 2019
Siglec-8 antibody reduces eosinophils and mast cells in a transgenic mouse model of eosinophilic gastroenteritisBradford A Youngblood, Emily C Brock, John Leung, et al.
JAMA|November 18, 2014
Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the HARMONIZE randomized clinical trialMikhail Kosiborod, Henrik S Rasmussen, Philip Lavin, et al.
The New England Journal of Medicine|November 22, 2014
Sodium zirconium cyclosilicate in hyperkalemiaDavid K Packham, Henrik S Rasmussen, Philip T Lavin, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 8, 2006
A randomized, double-blind, placebo-controlled, multicenter, pilot study of the safety and feasibility of catheter-based intramyocardial injection of AdVEGF121 in patients with refractory advanced coronary artery diseaseShmuel Fuchs, Nabil Dib, Barry M Cohen, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
The New England Journal of Medicine|April 18, 2015
New agents for hyperkalemiaDavid K Packham, Henrik S Rasmussen, Bhupinder Singh
Plos One|December 23, 2014
Characterization of structure and function of ZS-9, a K+ selective ion trapFiona Stavros, Alex Yang, Alejandro Leon, et al.
Kidney International|February 5, 2015
A phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, ZS-9, is safe and efficientStephen R Ash, Bhupinder Singh, Philip T Lavin, et al.
Drug Discovery Today|November 9, 2001
Looking into anti-angiogenic gene therapies for disorders of the eyeHenrik S. Rasmussen, Camilla S. Rasmussen, Rebecca G. Durham, et al.
The Lancet. Oncology|November 9, 2002
Radiation-induced tumour necrosis factor-alpha expression: clinical application of transcriptional and physical targeting of gene therapyRalph R Weichselbaum, Donald W Kufe, Samuel Hellman, et al.
The Journal of Allergy and Clinical Immunology|December 26, 2021
An open-label, proof-of-concept study of lirentelimab for antihistamine-resistant chronic spontaneous and inducible urticariaSabine Altrichter, Petra Staubach, Malika Pasha, et al.
JCI Insight|August 30, 2019
Siglec-8 antibody reduces eosinophils and mast cells in a transgenic mouse model of eosinophilic gastroenteritisBradford A Youngblood, Emily C Brock, John Leung, et al.
JAMA|November 18, 2014
Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the HARMONIZE randomized clinical trialMikhail Kosiborod, Henrik S Rasmussen, Philip Lavin, et al.
The New England Journal of Medicine|November 22, 2014
Sodium zirconium cyclosilicate in hyperkalemiaDavid K Packham, Henrik S Rasmussen, Philip T Lavin, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 8, 2006
A randomized, double-blind, placebo-controlled, multicenter, pilot study of the safety and feasibility of catheter-based intramyocardial injection of AdVEGF121 in patients with refractory advanced coronary artery diseaseShmuel Fuchs, Nabil Dib, Barry M Cohen, et al.
Pageof 2